If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Halstead Regulatory News (JHD)

Share Price Information for James Halstead (JHD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 201.00
Bid: 202.00
Ask: 205.00
Change: 1.50 (0.75%)
Spread: 3.00 (1.485%)
Open: 200.00
High: 205.00
Low: 198.50
Prev. Close: 199.50
JHD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

29 Mar 2012 07:00

RNS Number : 2957A
James Halstead PLC
29 March 2012
 



 

 

 

 

29 March 2012

 

 

JAMES HALSTEAD PLC

 

INTERIM RESULTS FOR THE HALF-YEAR ENDED 31 DECEMBER 2011

 

 

Key Figures

 

James Halstead plc, the AIM listed manufacturer and international distributor of commercial floor coverings, reports:

 

·;

Revenue increased to a record £117.7 million - an increase of 10.9%

·;

Operating profit increased to a record £20.8 million - an increase of 13.2%

·;

Pre-tax profit increased to a record £21.1 million - an increase of 14.1%

·;

Basic earnings per ordinary share increased to a record 14.4p - an increase of 16.1%

·;

Interim dividend increased to a record 5.0p - an increase of 11.1%

·;

Net cash at £36.9m - an increase of 22.9%

 

The Chief Executive, Mr Mark Halstead, commented:

 

"Having, once again, achieved record profits in challenging conditions, I recall in 1995 Sir John Harvey-Jones described our company as having "consistency of aim and performance with results obtained highlighting sound management principles as much as spectacular growth." I can confirm that we continue to adhere to these principles."

 

Enquiries:

 

Mark Halstead, Chief Executive

Gordon Oliver, Finance Director

Telephone: 0161 767 2500

Nick Lyon - Hudson Sandler

Telephone: 020 7796 4133

Ben Thorne - Altium Capital

Telephone: 020 7484 4076

 

Chris Hardie - Arden Partners

Telephone: 020 7614 5900

CHAIRMAN'S STATEMENT

It is pleasing for me to once more announce that we have achieved record turnover and record profit. Despite the regularity of making this statement we are not complacent that our ongoing success is in any way effortless or guaranteed. We continue to face challenging conditions and strong competition across the globe. Innovation, persistence and customer service remain crucially important.

 

Trading

 

 

Trading in the first half-year was very solid with record revenue of £117.7 million (2010: £106.1 million), an increase of 10.9%. The majority of the Group's activities are commercial flooring and the growth in many of our markets has been very encouraging.

 

Overseas sales increased by 15.2%. The growth in Germany was over 17% and France and Scandinavia outshone this with growth in excess of 25%. Our Australian sales were modestly ahead of last year but the comparative was itself 45% ahead of the prior year and exceeding this was truly an achievement. Polyflor Pacific continues to win hospital contracts, with the Waikato Hospital in Hamilton the latest example. In addition, it has also supplied the flooring for 150 new trams in Melbourne.

 

Halstead flooring continues to extend its global activities. Ireland is 25% ahead of the comparative and I am pleased to report our products are installed in the new Croke Park Stadium and Dublin Airport among a myriad of projects completed. In Russia we are supplying Nissan dealerships across the country as well as Otis lifts and the Borispol Airport in Kiev. As ever, the breadth of sales and the location of installations emphasise the global nature of our business.

 

Growth in the UK was lower with a 3.5% uplift and the UK proportion of total turnover now stands at 33%. Whilst this is the lowest proportion we have seen we also note that UK turnover is at record levels. This is an achievement in the market conditions that prevail in our home territory, and whilst there is much comment on the slow-down in new builds in our core healthcare and education markets, the refurbishment work in these areas remains buoyant. We continue to win hospital and school contracts in significant quantities, just a few examples being Royal London Hospital, The Christie Hospital, St. James in Leeds, Southampton Solent University and Liverpool John Moores University.

 

Our gross margin as a percentage has increased slightly in the last six months, as we anticipated in our budgets for the year. The nature of the world wide project business continues to mean that volume projects tend to be keenly priced. Raw materials prices are below the record levels seen in the last financial year but remain relatively high. Given our growth in sales we are satisfied with the situation and would expect to gain some productivity benefits in the second half of our financial year.

 

The profit before tax at £21.10 million (2010: £18.49 million) is another record performance and is 14.1% ahead of the comparative period. Cash inflow from operations was very positive at £23.10 million (2010: £19.27 million), some 19.8% ahead of the comparative period. We report £36.93 million of cash on the balance sheet (2010: £30.05 million). The cash at the end of the period is after significant outlays over the last 12 months, notably dividends of £14.90 million, taxation of £9.92 million, and purchase of shares for cancellation under a tender offer of £5.16 million.

  

The balance sheet continues to be robust. Stock is some 6.8% ahead of our 30 June level and 28% ahead of last year. This reflects investment in new product lines that are being launched into the market. By way of example, Polyflor has added its acclaimed easy-clean coating (PUR) to the Polysafe Standard collection to bring enhanced clean-ability of our safety floors to our full range and has introduced a new safety floor at the lower end of our portfolio, "Ecomax", using up to 45% recycled material. In addition to this we have launched Mineral fx and Simplay, all requiring launch stock for the distributors.

 

Riverside Flooring, the manufacturing facility acquired in December 2010, is now producing five ranges of flooring for supply into our network of operations. The facility is contributing to the overall results and offers impressive opportunities for growth. On top of the investments made to achieve this we have a plan for continued investment in Teesside in the coming years and having worked closely with the new Department for Business Innovation and Skills I can report that we have been successful in being awarded a grant of £1 million to support this investment. This is the first grant we have been awarded in the last 25 years!

 

Earnings per Share and Interim Dividend

 

 

Our basic earnings per share increased to a record 14.4p (2010: 12.4p), an uplift of 16.1%.

 

Having regard to these results and our strong cash balances the Board has the pleasant task of announcing, once again, an increased interim dividend.

 

We are proposing a dividend of 5.0p (2010: 4.5p), which represents an 11.1% increase on last year and is, yet again, a record interim payment.

 

Outlook

 

 

We continue to expand sales in almost all our markets with a continued growth in end users. We have recently supplied the flooring to Jamie Oliver's innovative "Ministry of Food" trucks; these custom built travelling kitchens / classrooms are traversing Australia to teach cooking skills. In Cologne, we have supplied "Music Store" Germany's renowned outlet for every type of music and instrument; at 44,000 m² it is the largest store of its type in Europe. Our success with new builds in healthcare and education continues: from the University of the West Indies and the King Saud University in Saudi Arabia to the Leon Becerra Hospital in Ecuador. In the UK our newly launched "Simplay" is being fitted in the Olympic Park in London.

 

We can be confident that the year will continue in a similar vein. There are significant new projects around the globe and ongoing refurbishment. We face new manufacturing capacity from our competitors every year but with sound management focus I have continued confidence in our ability to succeed in delivering shareholder value.

 

 

 

 

Geoffrey Halstead

Chairman

29 March 2012

Consolidated Income Statement

for the half-year ended 31 December 2011

 

Half-year 

ended 

31.12.11 

£'000 

Half-year 

ended 

31.12.10 

£'000 

Year 

ended 

30.06.11 

£'000 

Revenue

117,725 

106,131 

213,944 

Operating profit

20,819 

18,387 

38,310 

Net finance income

280 

98 

167 

Profit before income tax

21,099 

18,485 

38,477 

Income tax expense

(6,109)

(5,641)

(11,012)

Profit for the period

14,990 

12,844 

27,465 

Earnings per ordinary share of 5p:

-basic

14.4p

12.4p*

26.4p

-diluted

14.3p

12.3p*

26.3p

 

All the above figures relate to continuing operations.

 

Details of dividends paid and proposed are given in note 3

 

 

 

*Comparatives have been restated to reflect the effect of the one-for-one bonus share issue on 14 January 2011

 

Consolidated Balance Sheet

as at 31 December 2011

 

Half-year

ended

31.12.11

£'000

Half-year

ended

31.12.10

£'000

Year

ended

30.06.11

£'000

Non-current assets

Property, plant and equipment

32,511

35,063

33,631

Intangible assets

3,232

3,232

3,232

Deferred tax assets

7,294

7,144

5,911

43,037

45,439

42,774

Current assets

Inventories

52,201

40,792

48,862

Trade and other receivables

29,416

28,284

32,119

Derivative financial instruments

1,506

184

18

Cash and cash equivalents

36,928

30,054

34,031

120,051

99,314

115,030

Current liabilities

63,194

55,962

58,201

Net current assets

56,857

43,352

56,829

Non-current liabilities

Retirement benefit obligations

15,738

13,896

12,338

Deferred tax liabilities

922

957

921

Other payables

664

606

693

17,324

15,459

13,952

Net assets

82,570

73,332

85,651

Equity

Equity share capital

5,159

2,597

5,200

Equity share capital (B shares)

160

160

160

5,319

2,757

5,360

Share premium account

1,711

3,343

1,084

Retained earnings

62,592

55,307

65,839

Other reserves

12,948

11,925

13,368

Total equity attributable to shareholders of the parent

82,570

73,332

85,651

 

Consolidated Cash Flow Statement

for the half-year ended 31 December 2011

 

Half-year 

ended 

31.12.11 

£'000 

Half-year 

ended 

31.12.10 

£'000 

Year 

ended 

30.06.11 

£'000 

Cash inflow from operations

23,095 

19,270 

32,944 

Net interest received

124 

95 

131 

Taxation paid

(4,043)

(3,853)

(9,734)

Cash inflow from operating activities

19,176 

15,512 

23,341 

Purchase of property, plant and equipment

(1,371)

(9,934)

(9,696)

Proceeds from disposal of property, plant and equipment

240 

140 

252 

Cash outflow from investing activities

(1,131)

(9,794)

(9,444)

Equity dividends paid

(10,218)

(9,732)

(14,411)

Purchase of own shares

(5,156)

Shares issued

640 

315 

659 

Cash outflow from financing activities

(14,734)

(9,417)

(13,752)

Net increase/(decrease) in cash and cash equivalents

3,311 

(3,699)

145 

Effect of exchange differences

(414)

389 

522 

Cash and cash equivalents at start of period

34,031 

33,364 

33,364 

Cash and cash equivalents at end of period

36,928 

30,054 

34,031 

 

Consolidated Statement of Comprehensive Income

for the half-year ended 31 December 2011

 

Half-year 

ended 

31.12.11 

£'000 

Half-year 

ended 

31.12.10 

£'000 

Year 

ended 

30.06.11 

£'000 

 

Profit for the period

14,990 

12,844 

27,465 

 

Other comprehensive income net of tax:

Foreign currency translation differences

 (1,270)

2,242 

3,219 

Actuarial (loss)/gain on the defined benefit

pension scheme

 

(2,863)

 

2,163 

 

2,710 

Deferred taxation, change of rate

- 

35 

71 

Fair value movements on hedging instruments

796 

(1,377)

(911)

Other comprehensive income for the period net of tax

(3,337)

3,063 

5,089 

Total comprehensive income for the period

11,653 

15,907 

32,554 

Attributable to equity holders of the

parent company

11,653 

15,907 

32,554 

 

Notes to the Interim Results

for the half-year ended 31 December 2011

 

1.

Basis of preparation

 

The interim financial statements are unaudited and do not constitute statutory accounts as defined within the Companies Act 2006.

 

The principal accounting policies applied in the preparation of the consolidated interim statements are those set out in the annual report and accounts for the year ended 30 June 2011.

 

The figures for the year ended 30 June 2011 are an abridged statement of the group audited accounts for that year. The financial statements for the year ended 30 June 2011 were audited and have been delivered to the Registrar of Companies.

 

As is permitted by the AIM rules, the directors have not adopted the requirements of IAS34 'Interim Financial Reporting' in preparing the interim financial statements. Accordingly the interim financial statements are not in full compliance with IFRS.

2.

Income tax has been provided at the rate of 29.0% (2010: 30.5%).

 

3.

Dividends

Half-year

ended

31.12.11

£'000

Half-year

ended

31.12.10

£'000

Year

ended

30.06.11

£'000

Equity dividends paid:

 

Final dividend for the year ended 30 June 2010

-

9,732

9,732

Interim dividend for the year ended 30 June 2011

-

-

4,679

Final dividend for the year ended 30 June 2011

10,218

-

-

10,218

9,732

14,411

Equity dividends proposed at the end of the period

Interim dividend

5,161

4,679

-

Final dividend

-

-

10,218

 

 

Equity dividends per share, paid and proposed, are as follows:

 

·;

9.375p* final dividend for the year ended 30 June 2010, paid on 3 December 2010

·;

4.5p interim dividend for the year ended 30 June 2011, paid on 20 May 2011

·;

9.8p final dividend for the year ended 30 June 2011, paid on 2 December 2011

·;

5.0p interim dividend for the year ended 30 June 2012, payable on 18 May 2012 to those shareholders on the register at the close of business on 20 April 2012

 

 

*Reflects the effect of the one-for-one bonus issue on 14 January 2011

Notes to the Interim Results continued

for the half-year ended 31 December 2011

 

 

 

4.

Calculation of earnings per ordinary share

Half-year

ended

31.12.11

£'000

Half-year

ended

31.12.10

£'000

Year

ended

30.06.11

£'000

Basic earnings

14,990

12,844

27,465

Weighted average number of ordinary shares in issue

104,079,082

103,774,366*

103,856,972

Weighted average number of ordinary shares in issue (diluted for the effect of outstanding share options)

104,547,834

104,183,116*

104,347,570

Basic earnings per 5p ordinary share

14.4p

12.4p*

26.4p

Diluted earnings per 5p ordinary share

14.3p

12.3p*

26.3p

 

 

*Comparatives have been restated to reflect the effect of the one-for-one bonus issue on 14 January 2011

 

 

 

5.

 

 

 

 

 

 

 

6.

 

Purchase of own shares

 

On 5 December 2011 1,087,064 ordinary shares of 5p each were purchased for cancellation under a tender offer at a price of 474.28p amounting to £5,155,727.

 

 

 

 

Copies of the interim results

 

Copies of the interim results have been sent to shareholders. Further copies can be obtained from the Company's registered office, Beechfield, Hollinhurst Road, Radcliffe, Manchester, M26 1JN.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR SEMFIAFESELD
Date   Source Headline
8th Apr 20244:54 pmRNSPDMR Exercise of Share Options
3rd Apr 20242:00 pmRNSPDMR Acquisition of Shares
28th Mar 202412:00 pmRNSPDMR Grant of Share Options
27th Mar 20247:00 amRNSInterim Results
5th Mar 202412:30 pmRNSAppointment of Senior Independent Director
31st Jan 20247:00 amRNSTrading Update
4th Jan 20244:34 pmRNSBoard Changes
1st Dec 20232:25 pmRNSResults of Annual General Meeting
1st Dec 20237:00 amRNSAGM Statement
17th Nov 202311:13 amRNSPDMR Grant of Share Options
10th Nov 20234:45 pmRNSBlock Listing Six Monthly Return
10th Nov 20234:43 pmRNSBlock Listing Six Monthly Return
13th Oct 202312:00 pmRNSPosting of Annual R&A and Notice of AGM
2nd Oct 20237:00 amRNSPreliminary Results
1st Aug 20237:00 amRNSTrading Update
31st Mar 20231:57 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSInterim Results
2nd Feb 20237:00 amRNSTrading Update
1st Dec 20224:36 pmRNSResults of Annual General Meeting
1st Dec 20227:00 amRNSChairman’s Statement to the Annual General Meeting
14th Oct 20225:46 pmRNSPosting of Annual R&A and Notice of AGM
3rd Oct 20227:00 amRNSPreliminary Results
14th Sep 20221:01 pmRNSNotice of Preliminary Results
16th Aug 20223:59 pmRNSPDMR Exercise of Share Options
10th Aug 20224:00 pmRNSPDMR Grant of Share Options
1st Aug 20227:00 amRNSTrading Update
13th Jul 202211:24 amRNSBlock Listing Six Monthly Return
5th May 202210:48 amRNSTR-1: Notification of Major Holdings
31st Mar 20227:00 amRNSInterim Results
1st Feb 20227:00 amRNSTrading Update
17th Jan 202211:00 amRNSTotal Voting Rights and Application for Listing
13th Jan 20222:50 pmRNSApplication for Bonus Shares
7th Jan 20229:36 amRNSBlock Listing Six Monthly Return
7th Jan 20229:32 amRNSTotal Voting Rights
18th Nov 202111:13 amRNSResults of Annual General Meeting
18th Nov 20217:00 amRNSChairman’s Statement to the Annual General Meeting
15th Oct 20214:00 pmRNSPosting of Annual R&A and Notice of AGM
4th Oct 20217:00 amRNSPreliminary Results
20th Sep 20212:46 pmRNSNotice of Preliminary Results
4th Aug 20217:00 amRNSTrading Update
14th Jul 20215:00 pmRNSBlock Listing Six Monthly Return
25th Jun 20214:35 pmRNSPrice Monitoring Extension
22nd Jun 20214:00 pmRNSPDMR Exercise of Share Options
31st Mar 20217:00 amRNSInterim Results
1st Feb 20217:00 amRNSTrading Update
25th Jan 20217:00 amRNSBlock Listing Six Monthly Return
12th Nov 202011:00 amRNSResults of Annual General Meeting
12th Nov 20207:00 amRNSChairman's Statement to the Annual General Meeting
16th Oct 20204:00 pmRNSPosting of Annual Report and Notice of AGM
1st Oct 20207:00 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.